TARGET RESEARCH Clause Samples

The TARGET RESEARCH clause defines the scope and objectives of research activities to be conducted under an agreement. It typically outlines the specific research areas, goals, or deliverables that the parties are expected to pursue, and may set parameters such as timelines, milestones, or resource commitments. By clearly delineating the focus of research efforts, this clause ensures that both parties have a mutual understanding of expectations and helps prevent disputes over the direction or outcomes of the research.
TARGET RESEARCH. The Target Research shall commence upon the Effective Date and shall continue for three years thereafter, extendible for up to two additional years under substantially the same FTE funding and other terms as are set forth herein, with mutual consent. If the milestone described in Exhibit B is not met within 9 months after the First Amendment Date, Organon at its sole discretion may forthwith terminate the Target Research by written notice effective as of the first anniversary of the Effective Date. If the milestone described in Exhibit C is not met within 12 months after the First Amendment Date, Organon at its sole discretion may terminate the Target Research effective as of the end of the 18th month following the First Amendment Date. For purposes of this Agreement, the "Research Term" shall be the period from the Effective Date until the Target Research expires or is terminated pursuant to this Article 3. Under the Target Research 1. Confidential Treatment Requested 2
View SourceView Similar (3)
TARGET RESEARCH. The Target Research shall commence upon the Effective Date and shall continue for three years thereafter, extendible for up to two additional years under substantially the same FTE funding and other terms as are set forth herein, with mutual consent. If the milestone described in Exhibit B is not met within 8 months after the Effective Date Organon at its sole discretion may forthwith terminate the Target Research by written notice effective as of the first anniversary of the Effective Date. If the milestone described in Exhibit C is not met within 18 months after the Effective Date Organon at its sole discretion may terminate the Target Research effective as of the second anniversary of the Effective Date. For purposes of this Agreement, the "Research Term" shall be the period from the Effective Date until the Target Research expires or is terminated pursuant to this Article 3. Under the Target Research Signal shall use reasonable efforts to deliver up to [***] Research
View SourceView Similar (2)
TARGET RESEARCH. The Target Research shall commence upon the Effective Date and shall continue for three years thereafter, extendible for up to two additional years under substantially the same FTE funding and other terms as are set forth herein, with mutual consent. If the milestone described in Exhibit B is not met within [***] after the Effective Date Organon at its sole discretion may forthwith terminate the Target Research by written notice effective as of [***]. If the milestone described in Exhibit C is not met within [***] after the Effective Date Organon at its sole discretion may terminate the Target Research effective as of [***]. For purposes of this Agreement, the "Research Term" shall be the period from the Effective Date until the Target Research expires or is terminated pursuant to this Article 3. Under the Target Research Signal shall use reasonable efforts to deliver up to four Research Assays to Organon. If Organon elects to terminate the Target Research (a) [***] or (b) prior to receiving the [***] and paying the first milestone under Section 3.2.1(a), whichever is earlier, then this Agreement and all licenses granted hereunder shall terminate, except that the provisions listed in Section 9.3(b) shall survive. Otherwise, this Agreement shall survive termination or expiration of the Target Research.
View Source

Related to TARGET RESEARCH

  • Research Primary Investigator as part of a multi-site study (25 points) • Co-Investigator as part of a multi-site study (20 points) • Primary Investigator of a facility/unit based research study (15 points) • Co-Investigator of a facility/unit based research study (10 points) • Develops a unit specific research proposal (5 points) • Conducts a literature review as part of a research study (5 points)

  • Technology Research Analyst Job# 1810 General Characteristics

  • Program Inception Duration Program rolled out July 12, 2010. Based on the overwhelming need, funds allocated to this Program will likely be exhausted 3rd quarter 2014.

  • Influenza Vaccine Upon recommendation of the Medical Officer of Health, all employees shall be required, on an annual basis to be vaccinated and or to take antiviral medication for influenza. If the costs of such medication are not covered by some other sources, the Employer will pay the cost for such medication. If the employee fails to take the required medication, she may be placed on an unpaid leave of absence during any influenza outbreak in the home until such time as the employee has been cleared by the public health or the Employer to return to the work environment. The only exception to this would be employees for whom taking the medication will result in the employee being physically ill to the extent that she cannot attend work. Upon written direction from the employee’s physician of such medical condition in consultation with the Employer’s physician, (if requested), the employee will be permitted to access their sick bank, if any, during any outbreak period. If there is a dispute between the physicians, the employee will be placed on unpaid leave. If the employee gets sick as a reaction to the drug and applies for WSIB the Employer will not oppose the application. If an employee is pregnant and her physician believes the pregnancy could be in jeopardy as a result of the influenza inoculation and/or the antiviral medication she shall be eligible for sick leave in circumstances where she is not allowed to attend at work as a result of an outbreak. This clause shall be interpreted in a manner consistent with the Ontario Human Rights Code.

  • Collaboration 31.1 If the Buyer has specified in the Order Form that it requires the Supplier to enter into a Collaboration Agreement, the Supplier must give the Buyer an executed Collaboration Agreement before the Start date. 31.2 In addition to any obligations under the Collaboration Agreement, the Supplier must: 31.2.1 work proactively and in good faith with each of the Buyer’s contractors 31.2.2 co-operate and share information with the Buyer’s contractors to enable the efficient operation of the Buyer’s ICT services and G-Cloud Services